Download Robert A. Spurr U.S. Country Head and Vice President, Patient

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Market (economics) wikipedia , lookup

Transcript
Robert A. Spurr
U.S. Country Head and Vice President,
Patient Access and Health Policy for US General Medicines
Bob Spurr is US Country Head and Vice President, Patient Access and Health Policy for US
General Medicines at Novartis Pharmaceuticals Corporation (NPC). He is responsible for
strategically aligning resources to strengthen the value the company brings to leading customers,
including pharmacy benefit managers, insurers, Medicare, Medicaid, Veterans’ Affairs,
Department of Defense, senior care, chain pharmacies, wholesalers, employers, patients and
physicians. Bob is also responsible for leading US Health Policy, State Government Affairs, the
Patient & Specialty Services team, as well as sales, marketing and overall strategic development
of the company’s Established Medicines business. He is a member of the US Country Executive
Committee, the US General Medicines Executive Committee and the US Pharmaceutical
Executive Committee.
Bob, who has more than 25 years of commercial pharmaceutical experience in sales, marketing
and managed markets, most recently held the position of Head of Novartis US Oncology Market
Access. He began his career at Sandoz, serving in several sales and managed markets roles over
10 years, before moving to Aventis where he led a number of marketing and managed care
teams. Bob later joined Ortho-McNeil where he was Vice President of Sales and Marketing for
its Institutional Franchise. Before joining Novartis US Oncology in 2012, Bob held sales and
marketing executive leadership positions at Lantheus Medical Imaging and Repligen
Corporation.
Throughout his career, Bob has been an action-oriented leader, committed to ensuring that
appropriate patients have access to the medications they need. As Head of US Oncology Market
Access, he led overall strategic planning and tactical execution for all Oncology Managed
Markets/Market Access activities across the portfolio. Bob holds a Bachelor of Science degree
from Keene State College in New Hampshire and earned an Executive MBA from Rutgers, The
State University of New Jersey.